Today's was Seafarer Overseas Growth & Income (SFGIX) fund's third anniversary; it launched February 15, 2012. Steady asset growth despite a tough stretch for the emerging markets. Annual returns since inception are, per Morningstar, 8%. The category average for the same period is 1%. The big gains came in the first year but he's steadily outperformed since then, too.
I'm not sure why the fund won't debut as a Five Star, Great Owl but I've been surprised before.
With luck, Andrew will join us for a conference call in April. You'd certainly be welcome to join if you'd like to talk with him.
As ever,
David
Comments
David,
In your opinion would SFGIX (SIGIX) be a replacement for MAPIX?
I currently own MAPIX and MACSX.
Mona
Here are numbers through January. Slams the category.
The risk numbers are much better too, even though our current methodology pegs it at 5. In our update next month, that will likely go to 4. In this bull market, everything "looks" risky when compared to SP500. If I get the update incorporated sooner, will post.
But the basic metrics speak for themselves.
Seems to me Mr. Foster and crew have delivered as promised. Fortunately, we own one of first accounts...a rare enlightened moment .
There's not much overlap between the two funds, so it's hard to call one a substitute for the other. MAPIX is about 50/50, emerging and developed with a 25% stake in Japan, 70% large to mega cap. Seafarer is about 70/30 with the 30 beginning developed Asian markets but not Japan, 35% large to mega cap. And of course Seafarer is 60% Asia to MAPIX at 100%. So Seafarer has a smaller market cap, no Japan but a substantial chunk in Europe (15%) and Latin America (15%).
Too, Seafarer is $130 million against $5 billion for the two Matthews' funds.
That said, all are very risk conscious, well-managed and substantially driven by the fate of emerging Asia.
Sorry for the wimpy response.
David
Typical of Andrew's caution, he posted a warning about the source of the "caught fire" period. An Indian pharma company popped 70% in a week, making it the firm's largest holding. Here's an excerpt of Andrew's special letter to shareholders following the pop: Andrew's letter had been discussed earlier, but I thought it wise to highlight it again given this thread.
Andrew was in India this week. I'll be curious to read his Field Notes on the experience.
For what interest it holds,
David
Regards,
Ted
If I'm reading this right , more drag on performance.
Derf
One simple expedient would be to drop a note to Seafarer and ask. In general, expense waivers are almost never revoked although many contain a "clawback" provision. At base, advisers sometimes subsidize a fund until it hits a breakeven point but then they don't lower the expense ratio further until they've recouped some or all of the money they spent underwriting fund operations. In Seafarer's case, they can recoup expenses for the three years immediately prior to when they turn profitable.
Andrew joked at one point that he and I both run non-profit entities, the difference between that I do it on purpose.
A concern for shareholders is, I believe, part of Seafarer's DNA. They've repeatedly lowered their expense ratio, despite the fact that Morningstar wouldn't give them credit for the move since Morningstar uses the expense ratios from the annual report. Morningstar reports a 1.4% e.r. for Seafarer, which reflects the April 2014 Annual Report's calculation of the fund's 2013 expenses. The September 2014 prospectus commits to a 1.25% e.r. but Morningstar's profile of the fund in 2015 reports the expenses investors bore in 2013 as if they were current.
As ever,
David
Edit, looks like the sea farer pop in January has put it slightly ahead of MACSX
http://quotes.morningstar.com/fund/f?t=SFGIX®ion=USA